United Therapeutics (UTHR) Tops Q1 EPS by 19c, Miss on Revenues

United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $3.76, $0.19 better than the analyst estimate of $3.57. Revenue for the quarter came in at $389.2 million versus the consensus estimate of $401.94 million.

For earnings history and earnings-related data on United Therapeutics (UTHR) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
• Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c